Shareholding disclosure

Nadine Zahnd-Straumann

Declared position

3.42%

Threshold

Crossed upwards

Timeline

Published

06.12.2017

Transaction

08.11.2017

Voting rights breakdown

Voting rights acquired3.42%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAHBM00045

Beneficial owner

Nadine Zahnd-Straumann

Declared address

Nadine Zahnd-Straumann, Zürich

Erbengemeinschaft Christian Zahnd (vertreten durch Nadine Zahnd-Straumann)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Nadine Zahnd-Straumann

Molecular Partners AG06.12.2017TAHBM00045

Disclosure summary

Nadine Zahnd-Straumann disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 06.12.2017, at 3.42% of voting rights. Notice category: Single shareholder.

Disclosed position

3.42%

Voting rights acquired

Voting rights acquired3.42%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Nadine Zahnd-Straumann disclosed a holding in Molecular Partners AG, published on 06.12.2017.

Publication date06.12.2017

Transaction date08.11.2017

Issuing companyMolecular Partners AG

Beneficial ownerNadine Zahnd-Straumann

Declared addressNadine Zahnd-Straumann, Zürich

CategorySingle shareholder

Voting rights acquired3.42%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAHBM00045

Conditions

Erbengemeinschaft Christian Zahnd (vertreten durch Nadine Zahnd-Straumann)

Source: SIX Exchange Regulation · Publication date: 06.12.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open